NCT02372812

Brief Summary

A randomised controlled clinical trial to assess the effect of intraoperative dexamethasone on the 24 hour post operative pain scores of adult patients in Mulago hospital undergoing mastectomies, laparotomies and thyroidectomies. The adverse effects of dexamethasone at this dose were also assessed for.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
173

participants targeted

Target at P75+ for phase_2 pain

Timeline
Completed

Started Jul 2014

Shorter than P25 for phase_2 pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2014

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

February 20, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 26, 2015

Completed
Last Updated

April 23, 2015

Status Verified

April 1, 2015

Enrollment Period

7 months

First QC Date

February 20, 2015

Last Update Submit

April 22, 2015

Conditions

Keywords

effect of dexamethasonegeneral surgerypost operative

Outcome Measures

Primary Outcomes (1)

  • Post- operative pain scores of the patients using the numerical rating scale, that grades pain from 1-10. The patients will have this scale explained to them. This will be done 24 hours following administration of intraoperative dexamethasone.

    pain scores assessed using the numerical rating scale, at three points i.e the PACU, 12 and 24 hours post operatively

    1 year

Secondary Outcomes (1)

  • : Adverse effects of the dexamethasone

    1 year

Study Arms (2)

group1

ACTIVE COMPARATOR

12 mg( 3 mls) of dexamethasone given 15 mins after induction of anesthesia

Drug: dexamethasone

group2

PLACEBO COMPARATOR

3 mls of placebo( normal saline) given 15 mins after induction of anesthesia

Drug: Placebo

Interventions

12 mg of dexamethasone

group1
group2

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled for mastectomies, laparotomies and thyroidectomies that have given informed consent to participate.
  • ASA I \& II, patients that have none or have mild to moderate systemic illness.
  • Adult patients, above 18 years old.

You may not qualify if:

  • Patients with Cushing's disease or Cushing's syndrome
  • Patients with diabetes mellitus
  • Systemic infection
  • Previous history of TB infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mulago Hospital National Refferal, surgical wards

Kampala, +256, Uganda

Location

MeSH Terms

Conditions

Pain

Interventions

Dexamethasone

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, Fluorinated

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical doctor

Study Record Dates

First Submitted

February 20, 2015

First Posted

February 26, 2015

Study Start

July 1, 2014

Primary Completion

February 1, 2015

Study Completion

February 1, 2015

Last Updated

April 23, 2015

Record last verified: 2015-04

Locations